FDA Survey Comment Form
Summary
The Food and Drug Administration (FDA) has opened a public comment period on a survey (Docket FDA-2026-N-2740-0001) via regulations.gov. The comment period remains open until June 2, 2026. This is a standard consultation seeking public input on an unspecified FDA survey topic.
What changed
FDA has published a comment form for a survey (FDA-2026-N-2740-0001) on regulations.gov. The consultation is open for public comments through June 2, 2026. Commenters may submit feedback as individuals, organizations, or anonymously, with support for file attachments up to 10MB.
Regulated entities and stakeholders who wish to provide input on FDA survey questions or methodology should submit comments by June 2, 2026. No specific compliance obligations or penalties are associated with this consultation. Parties should note that any personally identifiable information submitted may be publicly disclosed.
Source document (simplified)
Write a Comment
Commenter's Checklist
Public Comments on Federal Regulations
Comment *
5000
What is your comment about?
Attach Files
You can attach up to 20 files, but each file cannot exceed 10MB. Valid file types include: bmp, docx, gif, jpg, jpeg, pdf, png, pptx, rtf, sgml, tif, tiff, txt, wpd, xlsx, xml. Drop files here or Browse...
Email Address
Opt to receive email confirmation of submission and tracking number?
If you choose to identify as Anonymous, the option to receive an email confirmation will not be displayed. (We will never post the email address entered in the field above on Regulations.gov nor share it with anyone else.)
Tell us about yourself! I am... *
(Select an identity below)
An Individual
Yourself or another person whom
you represent with their consent
An Organization
A company, organization,
or government agency
Anonymous
A person who does not want their name
associated with the comment
Note: If you choose to identify as Anonymous, the option to enter your email address for submission confirmation is not available.
reCAPTCHA *
Solve with 2Captcha Do not submit personally identifiable information through this form. Any personally identifiable information (e.g., name, address, phone number) included in the comment form or in an attachment may be publicly disclosed in a docket or on the Internet (via Regulations.gov, a federal agency website, or a third-party, non-government website with access to publicly-disclosed data on Regulations.gov). By submitting a comment, you agree to the terms of participation and privacy notice.
Submit Comment
Please see the Privacy Notice and User Notice regarding comment submission.
Any information (e.g., personal or contact) you provide on this comment form or in an attachment may be publicly disclosed and searchable on the Internet and in a paper docket and will be provided to the Department or Agency issuing the notice. To view any additional information for submitting comments, such as anonymous or sensitive submissions, refer to the Privacy Notice and User Notice, the Federal Register notice on which you are commenting, and the Web site of the Department or Agency.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.